Takayuki Mizutani
Direttore/Membro del Consiglio presso Theoria Science KK
Posizioni attive di Takayuki Mizutani
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Theoria Science KK
 Theoria Science KK BiotechnologyHealth Technology Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests. | Direttore/Membro del Consiglio | 01/01/2014 | - |
Storia della carriera di Takayuki Mizutani
Precedenti posizioni note di Takayuki Mizutani
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
B-Bridge International, Inc.
 B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | - | - |
Formazione di Takayuki Mizutani
| California State University-Chico | Graduate Degree |
| The Ohio State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Giappone | 2 |
Posizioni
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
B-Bridge International, Inc.
B-Bridge International, Inc. BiotechnologyHealth Technology B-Bridge International, Inc. manufactures biological products. It offers antibodies synthetic substitutes, cells, general reagents, IHC staining reagents, instruments, and kinase inhibitors. The company was founded by Hiroyuki Masumoto in 2000 and is headquartered in Santa Clara, CA. | Health Technology |
Theoria Science KK
Theoria Science KK BiotechnologyHealth Technology Theoria Science KK is a company founded in 2012 and based in Tokyo, Japan. The Japanese company specializes in exosome research and offers the latest clinical knowledge and expertise in the field. Theoria Science is focused on developing early detection methods and therapeutic drugs for various diseases, including blood cancer. The company also provides medical services related to exosome research, such as early risk detection tests. | Health Technology |
- Borsa valori
- Insiders
- Takayuki Mizutani
- Esperienza
